- Professor of Medicine, Divisions of Rheumatology and Allergy, Department of Medicine, Johns Hopkins University
- Director, Johns Hopkins Arthritis Center
- Vice Chair for Clinical and Translational Research, Department of Medicine
- Deputy Director for Research, Division of Rheumatology
- Director, Center for Patient Centered Outcomes Research in Rheumatology
- Co-Director, Rheumatic Diseases Research Core Center
- Director, Johns Hopkins Arthritis Website
- Rheumatoid Arthritis, Spondlyoarthritis, Other forms of Inflammatory Arthritis, and Osteoarthritis
- Patient reported outcomes in arthritis
- Patient and health care provider education
Dr. Bingham’s research interests are to identify clinical and pathophysiologic disease phenotypes of inflammatory arthritis including rheumatoid arthritis (RA), psoriatic arthritis (PsA), and osteoarthritis (OA) to improve patient-centered care and health outcomes for people living with these diseases. His career has spanned from the bench to the bedside. His initial research was focused on laboratory-based studies evaluating basic mechanisms of inflammation. He then transitioned to a clinical-translational research focus with extensive experience in the design, conduct, and analysis of clinical trials of new therapies for RA, OA, and other autoimmune diseases. His most recent work has focused on improving the ways in which disease activity is measured. For more than 15 years, a major focus of his research has been better understanding the patient’s perspective of their disease experience and life impact, identifying and developing measures to reflect these aspects of health-related quality of life, piloting and validating patient-reported outcome measures in arthritis, and integrating this information into routine clinical care and clinical trials. He co-chairs the Technical Advisory Group for the international Outcome Measures in Rheumatology (OMERACT) group, which works to develop core sets of measures for use in clinical trials and observational research. He was a member of the international group that revised the classification criteria for RA, permitting the diagnosis of earlier disease to facilitate treatment with disease modifying agents and for recent updated vaccination guidelines for rheumatic diseases.
His current research focuses on defining clinical and biochemical disease phenotypes related to therapeutic responses in RA and OA, developing rational clinical trial designs to test new treatments, improved patient-reported outcomes and clinical outcome measures, and integrating precision medicine into clinical care.
He is author of more than 250 publications, reviews, and book chapters, several topics in UpToDate, and numerous abstracts. A listing of some of these publications can be found by clicking on this link.
- M.D.: Columbia University College of Physicians and Surgeons, New York, NY
- Internship and Residency (Internal Medicine): Columbia-Presbyterian Medical Center, New York, NY
- Post-doctoral Fellowships (Rheumatology, Allergy and Clinical Immunology): Brigham and Women’s Hospital, Boston, MA
- American College of Rheumatology (ACR)
- Outcome Measures in Rheumatology (OMERACT)
- International Society of Quality of Life Research (ISOQoL)
- Associate Editor, RMD Open, a journal of the European League against Rheumatism (EULAR)
- Past Co-Editor, Arthritis and Rheumatism, journal of the American College of Rheumatology (ACR)
- Associate Editor, Clinical Care in the Rheumatic Diseases (3rd Edition)
- He has been active in ACR and Arthritis Foundation committees and has chaired meetings, study groups, and grant review sections.